Back to News
Market Impact: 0.35
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
Source: zacks.com
M&A & RestructuringHealthcare & BiotechCompany Fundamentals
OPK agreed to sell BioReference assets to Labcorp for $722 million, with a potential $150 million earnout. OPK says the sale will sharpen its focus on biopharma and expand access to its 4Kscore Test.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
LH0.15
OPK0.45
More News
- Why did CoreWeave stock get crushed this week? Look to this corner of the debt market for clues
- AI stock sell-off ramps up over debt-fueled data center spending fears: ‘Full-blown crisis of confidence'
- All the news about the iPhone Duo
- The Tesla Roadster should go into production in 2028, but don't get your hopes up
- Apple’s $1,999 iPhone Duo puts the company's status-symbol power to the test
- Yields continue to rattle investors. These sectors are most at risk if rates stay elevated
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Vendor Landscape for Institutional Investment Teams
- AllMind Fixed Income Compass for October 2025: Navigating Policy Divergence and Political Risk